Colorado researchers report early fertility signal for injectable semaglutide

The wire

1. 01The university reports early findings that injectable semaglutide improved fertility outcomes in women with polycystic ovary syndrome.
2. 02Clinicians already field questions about GLP-1 use and conception, and PCOS is a common reason patients seek metabolic therapy off-label.
3. 03Findings are described as early; sample size, endpoints and peer-review status determine how much weight the result can carry.

From the source

Injectable Semaglutide Shows Early Promise to Improve Fertility in Women with PMOS